Cambridge, MA, United States of America

Joshua T Close

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):

Title: **Innovative Mind: Joshua T Close**

Introduction

Joshua T Close is a prominent inventor based in Cambridge, MA, known for his contributions to the field of pharmaceutical innovation. With a total of three patents to his name, Close has made significant strides in developing treatments aimed at regulating MAP4K1 activity, a key process in various diseases.

Latest Patents

Close’s most recent patents focus on MAP4K1 inhibitors. One embodiment of his disclosure describes a compound represented by Formula I, along with pharmaceutically acceptable salts thereof. These compounds are designed to regulate MAP4K1 activity, offering therapeutic options for conditions that benefit from such control. The selective nature of these MAP4K1 inhibitors further enhances their potential clinical applications.

Career Highlights

Joshua T Close is currently employed at Blueprint Medicines Corporation, where he applies his expertise to advance innovations in the pharmaceutical sector. His work contributes not only to the company's mission but also to the broader field of medicine, addressing complex health issues through targeted therapeutic strategies.

Collaborations

Throughout his career, Close has collaborated with esteemed colleagues such as Jason D. Brubaker and Chandrasekhar V. Miduturu. These partnerships foster a collaborative environment that enhances the development of groundbreaking treatments and innovations within the industry.

Conclusion

In summary, Joshua T Close exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborative efforts continue to pave the way for advancements in medical treatments, demonstrating the profound impact inventors can have on health and wellbeing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…